Saccharomyces Boulardii

Here is the one thing that makes Saccharomyces boulardii different from every other probiotic on the shelf: it is a yeast, not a bacterium. That sounds like trivia until you are on antibiotics. Antibiotics kill bacteria, including the friendly ones in a normal probiotic capsule, but they leave a yeast untouched. So S. boulardii is the rare probiotic you can take at the same time as your antibiotic and expect to still be working. That is exactly the situation it has the best evidence for. A meta-analysis of 21 randomized trials (Szajewska & Kolodziej 2015) found it roughly halved the risk of antibiotic-associated diarrhea. If you are starting a course of antibiotics and want to lower the odds of the diarrhea that often comes with them, this is a reasonable, well-studied move.

Beyond antibiotics, the evidence gets more specific. In children with acute infectious diarrhea, a meta-analysis found it shortened the episode by about a day (Szajewska et al. 2007) - meaningful for a sick toddler, less relevant for a healthy adult. As an add-on during H. pylori treatment it modestly improved eradication and, more usefully, cut the side effects of that rough antibiotic regimen (Szajewska et al. 2015). For recurrent C. difficile it may help as a vancomycin adjunct, but the adult data are inconsistent - a 2023 meta-analysis found the benefit significant in children and not in adults, so treat this as unsettled, not proven. For preventing travelers' diarrhea the signal is real but destination-dependent (McFarland 2010). It is not an everyday supplement for a healthy gut; it is a targeted tool for specific windows.

The safety framing matters more here than with most probiotics, and it is the reason to read the label rather than the marketing. Because S. boulardii is a live yeast, it can in rare cases enter the bloodstream (fungemia). Those documented cases occur almost entirely in a specific group: people who are immunocompromised (chemotherapy, transplant, HIV, immunosuppressant drugs), people who are critically ill or in intensive care, and people with a central venous catheter - where the risk is partly mechanical, from yeast contaminating the line when a capsule is opened nearby. For a healthy person taking it by mouth, it is very well tolerated, with mild gas or bloating the usual worst case. But if you or someone you are buying for is in one of those high-risk groups, this is a talk-to-your-doctor supplement, not a grab-off-the-shelf one.

On products, the honest quality signal is the strain. Most of the trials above used one specific strain, CNCM I-745, which is the strain in Florastor. Many competing products just say "Saccharomyces boulardii" with no strain code at all - not necessarily worse yeast, but you are trusting that it behaves like the studied one without the label telling you so, which is a fair knock in a category where strain identity is the whole game. Because these are living organisms, also look for CFU guaranteed through the expiration date rather than only "at time of manufacture," which tells you nothing about what is alive when you swallow it.